NCT03292328已完成不适用
Yoga for Chemotherapy-Induced Peripheral Neuropathy in Breast and GYN Cancer Survivors: A Pilot Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 51
- 试验地点
- 3
- 主要终点
- Change in treatment related peripheral neuropathy symptoms
研究概览
简要总结
Some types of chemotherapy used to treat breast cancer can cause damage to nerves with symptoms like tingling, numbness, muscle weakness, and pain in the hands and feet that can last and can affect functioning. The purpose of this study is to find out the effects of yoga on reducing symptoms caused by such nerve damage.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •English-speaking
- •Age >/= 18 years old
- •Survivors with a primary diagnosis of stage I-III breast, ovarian uterine, or endometrial cancer
- •Moderate to severe chemotherapy induced peripheral neuropathy, defined by symptoms such as numbness, tingling, or pain ratings of 4 or greater on a 0-10 numeric rating scale
- •Have completed neurotoxic chemotherapy, i.e. taxanes (paclitaxel, docetaxel) and platinum (carboplatin) at least 3 months prior to enrollment
- •If taking anti-neuropathy medications, they are on a stable regiment (no change in 3 months)
- •ECOG performance status 0-2
排除标准
- •Participants with metastatic disease
- •Participants who are currently receiving physical therapy or practicing yoga for any reason
- •Control Group - Inclusion/Exclusion Criteria
- •Inclusion Criteria:
- •English speaking
- •Age >/= 18 years old
- •Survivors with a primary diagnosis of Stage I-III breast, ovarian, uterine, or endometrial cancer
- •CIPN symptoms such as numbness, tingling, or pain ratings < 2 on a 0-10 NRS scale
- •Have completed neurotoxic chemotherapy, i.e. taxanes (paclitaxel, docetaxel) and platinum (carboplatin) at least 3 months prior to enrollment
- •ECOG performance status 0-2
- •Exclusion Criteria:
- •Patients with metastatic disease
- •Patients taking anti-neuropathy medication
- •Patients who are currently receiving physical therapy or practicing yoga for any reason
结局指标
主要结局
Change in treatment related peripheral neuropathy symptoms
时间窗: 8 weeks of the participants' most bothersome peripheral neuropathy symptom
Treatment related symptoms will be evaluated by using NCI CTCAE v4.0
次要结局
未报告次要终点
研究者
研究点 (3)
Loading locations...
相似试验
已完成
不适用
Meridian Yoga on Chemotherapy-induced Peripheral Neuropathy in Breast Cancer PatientsCIPN - Chemotherapy-Induced Peripheral NeuropathyBreast CancerNCT05959811China Medical University Hospital80
终止
不适用
Heading Off Peripheral Neuropathy With ExercisePeripheral Nervous System DisordersBreast NeoplasmsChemotherapyNCT00869804University of Nebraska19
尚未招募
不适用
CIPN and it's Impact on Quality of Life in Patients Receiving Platinum and TaxanesChemotherapy-induced Peripheral NeuropathyNCT05829967Assiut University60
招募中
4 期
Preventive Approach Using VenlafaxinePeripheral Neuropathy Due to ChemotherapyNCT05875610Mit Ghamr Oncology Center60
已完成
不适用
Chemotherapy-induced peripheral neuropathy in cancer patients – A four arm randomized trial on the effectiveness of electro-acupunctureG63.1Polyneuropathy in neoplastic diseaseDRKS00004448Klinik für Tumorbiologie an der Albert Ludwigs Universität Freiburg60